| Date Filed | Type | Description |
| 08/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/20/2023 |
SC 13G
| Roumell Asset Management, LLC reports a 7% stake in GSI Technology, Inc. |
| 11/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/11/2022 |
SC 13G/A
| Roumell Asset Management, LLC reports a 0.6% stake in TETRA Technologies Inc. |
| 02/11/2022 |
SC 13G
| Roumell Asset Management, LLC reports a 6.2% stake in Qumu Corporation |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/07/2022 |
SC 13D/A
| Roumell Asset Management, LLC reports a 3.3% stake in BioCardia, Inc. |
| 01/20/2022 |
SC 13D/A
| Roumell Asset Management, LLC reports a 8.1% stake in GSI Technology, Inc. |
| 11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 09/30/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 6% stake in Enzo Biochem, Inc. |
| 09/22/2021 |
SC 13D
| Roumell Asset Management, LLC reports a 5.6% stake in BioCardia, Inc. |
| 09/14/2021 |
SC 13D
| Roumell Asset Management, LLC reports a 8.1% stake in GSI Technology, Inc. |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/05/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 6% stake in Enzo Biochem, Inc. |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/12/2021 |
SC 13G
| Roumell Asset Management, LLC reports a 5.7% stake in GSI Technology Inc. |
| 02/12/2021 |
SC 13G
| Roumell Asset Management, LLC reports a 8.2% stake in TETRA Technologies Inc. |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/15/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 01/05/2021 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 01/05/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/31/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/31/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 12/28/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 12/23/2020 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 12/23/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/23/2020 |
DEFC14A
| Form DEFC14A - Definitive proxy statement, contested solicitations: |
|